OIS Podcast | Ophthalmology's leading Podcast
Welcome to the Ophthalmology Innovation Podcast Where you get Candid Conversations with the Leaders and Drivers of Ophthalmic Innovation. OIS is the Largest and Original Producer of World-Class Ophthalmology Innovation Conferences and Content Since 2009.
OIS Podcast | Ophthalmology's leading Podcast
Trial by Fire: Designing and Executing Ophthalmic Studies That Deliver
Use Left/Right to seek, Home/End to jump to start or end. Hold shift to jump forward or backward.
PANELIST (TITLE and AFFILIATION):
- Richard L. Beckman, M.D., Principal, RLB, M.D. Consulting, LLC
- Malvina Eydelman, M.D., CEO, The Collaborative Community on Ophthalmic Innovation
MODERATOR: Barbara Wirostko, M.D., FARVO, CMO and Co-Founder, Qlaris Bio
Description:
How should you design your first-in-human study? Richard L. Beckman, M.D., principal of RLB, M.D. Consulting, LLC, and Malvina Eydelman, M.D., CEO of the Collaborative Community on Ophthalmic Innovation, sit down on a panel at OIS Ignite 2025, moderated by Barbara Wirostko, M.D., FARVO, CMO and co-founder, Qlaris Bio, to discuss what goes into designing first-in-human studies, including the preclinical work, the right people to advise you, and considering the population and patients. Also, stay tuned for updates on the next OIS Ignite, taking place on March 2027!
In this episode, learn about:
- How the FDA can help and if it’s ever “too early” to reach out to them
- The FDA’s perspective
- Establishing a target product profile
- If a DSMB is recommended for trials
RESOURCES:
Barbara Wirostko: https://ois.net/barbara-wirostko-md-farvo/
Richard L. Beckman: https://ois.net/richard-rick-l-beckman-md/
Malvina Eydelman: https://ois.net/malvina-eydelman/